Single Nucleotide Polymorphism (SNP) Genotyping Market Size to Hit USD 42.12 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Single Nucleotide Polymorphism (SNP) Genotyping Market

5.1. COVID-19 Landscape: Single Nucleotide Polymorphism (SNP) Genotyping Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porters Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, By End-User

8.1. Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue and Volume Forecast, by End-User

8.1.1. Pharmaceutical & Biotechnology Companies

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Diagnostic Laboratories/Clinical Labs

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Academic & Research Institutes

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Agricultural/Livestock Genomics Firms

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Contract Research Organizations (CROs)/Service Providers

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, By Technology

9.1. Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue and Volume Forecast, by Technology

9.1.1. PCR-based Genotyping

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Microarrays/Gene Chips

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Mass Spectrometry/MALDI-TOF

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, By Product/Component

10.1. Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue and Volume Forecast, by Product/Component

10.1.1. Instruments

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Reagents & Kits

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Software & Bioinformatics Services

10.1.3.1. Market Revenue and Volume Forecast

Chapter 11. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, By Application

11.1. Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue and Volume Forecast, by Application

11.1.1. Pharmaceuticals & Pharmacogenomics

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Diagnostic Research

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Agricultural Biotechnology

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Breeding & Animal Livestock

11.1.4.1. Market Revenue and Volume Forecast

Chapter 12. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by End-User

12.1.2. Market Revenue and Volume Forecast, by Technology

12.1.3. Market Revenue and Volume Forecast, by Product/Component

12.1.4. Market Revenue and Volume Forecast, by Application

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by End-User

12.1.5.2. Market Revenue and Volume Forecast, by Technology

12.1.5.3. Market Revenue and Volume Forecast, by Product/Component

12.1.5.4. Market Revenue and Volume Forecast, by Application

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by End-User

12.1.6.2. Market Revenue and Volume Forecast, by Technology

12.1.6.3. Market Revenue and Volume Forecast, by Product/Component

12.1.6.4. Market Revenue and Volume Forecast, by Application

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by End-User

12.2.2. Market Revenue and Volume Forecast, by Technology

12.2.3. Market Revenue and Volume Forecast, by Product/Component

12.2.4. Market Revenue and Volume Forecast, by Application

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by End-User

12.2.5.2. Market Revenue and Volume Forecast, by Technology

12.2.5.3. Market Revenue and Volume Forecast, by Product/Component

12.2.5.4. Market Revenue and Volume Forecast, by Application

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by End-User

12.2.6.2. Market Revenue and Volume Forecast, by Technology

12.2.6.3. Market Revenue and Volume Forecast, by Product/Component

12.2.6.4. Market Revenue and Volume Forecast, by Application

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by End-User

12.2.7.2. Market Revenue and Volume Forecast, by Technology

12.2.7.3. Market Revenue and Volume Forecast, by Product/Component

12.2.7.4. Market Revenue and Volume Forecast, by Application

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by End-User

12.2.8.2. Market Revenue and Volume Forecast, by Technology

12.2.8.3. Market Revenue and Volume Forecast, by Product/Component

12.2.8.4. Market Revenue and Volume Forecast, by Application

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by End-User

12.3.2. Market Revenue and Volume Forecast, by Technology

12.3.3. Market Revenue and Volume Forecast, by Product/Component

12.3.4. Market Revenue and Volume Forecast, by Application

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by End-User

12.3.5.2. Market Revenue and Volume Forecast, by Technology

12.3.5.3. Market Revenue and Volume Forecast, by Product/Component

12.3.5.4. Market Revenue and Volume Forecast, by Application

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by End-User

12.3.6.2. Market Revenue and Volume Forecast, by Technology

12.3.6.3. Market Revenue and Volume Forecast, by Product/Component

12.3.6.4. Market Revenue and Volume Forecast, by Application

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by End-User

12.3.7.2. Market Revenue and Volume Forecast, by Technology

12.3.7.3. Market Revenue and Volume Forecast, by Product/Component

12.3.7.4. Market Revenue and Volume Forecast, by Application

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by End-User

12.3.8.2. Market Revenue and Volume Forecast, by Technology

12.3.8.3. Market Revenue and Volume Forecast, by Product/Component

12.3.8.4. Market Revenue and Volume Forecast, by Application

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by End-User

12.4.2. Market Revenue and Volume Forecast, by Technology

12.4.3. Market Revenue and Volume Forecast, by Product/Component

12.4.4. Market Revenue and Volume Forecast, by Application

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by End-User

12.4.5.2. Market Revenue and Volume Forecast, by Technology

12.4.5.3. Market Revenue and Volume Forecast, by Product/Component

12.4.5.4. Market Revenue and Volume Forecast, by Application

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by End-User

12.4.6.2. Market Revenue and Volume Forecast, by Technology

12.4.6.3. Market Revenue and Volume Forecast, by Product/Component

12.4.6.4. Market Revenue and Volume Forecast, by Application

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by End-User

12.4.7.2. Market Revenue and Volume Forecast, by Technology

12.4.7.3. Market Revenue and Volume Forecast, by Product/Component

12.4.7.4. Market Revenue and Volume Forecast, by Application

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by End-User

12.4.8.2. Market Revenue and Volume Forecast, by Technology

12.4.8.3. Market Revenue and Volume Forecast, by Product/Component

12.4.8.4. Market Revenue and Volume Forecast, by Application

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by End-User

12.5.2. Market Revenue and Volume Forecast, by Technology

12.5.3. Market Revenue and Volume Forecast, by Product/Component

12.5.4. Market Revenue and Volume Forecast, by Application

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by End-User

12.5.5.2. Market Revenue and Volume Forecast, by Technology

12.5.5.3. Market Revenue and Volume Forecast, by Product/Component

12.5.5.4. Market Revenue and Volume Forecast, by Application

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by End-User

12.5.6.2. Market Revenue and Volume Forecast, by Technology

12.5.6.3. Market Revenue and Volume Forecast, by Product/Component

12.5.6.4. Market Revenue and Volume Forecast, by Application

Chapter 13. Company Profiles

13.1. QIAGEN N.V.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial PerEnd-Userance

13.1.4. Recent Initiatives

13.2. Bio-Rad Laboratories

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial PerEnd-Userance

13.2.4. Recent Initiatives

13.3. Danaher Corporation

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial PerEnd-Userance

13.3.4. Recent Initiatives

13.4. Beckman Coulter

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial PerEnd-Userance

13.4.4. Recent Initiatives

13.5. Luminex Corporation

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial PerEnd-Userance

13.5.4. Recent Initiatives

13.6. PerkinElmer

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial PerEnd-Userance

13.6.4. Recent Initiatives

13.7. Fluidigm Corporation

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial PerEnd-Userance

13.7.4. Recent Initiatives

13.8. Affymetrix

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial PerEnd-Userance

13.8.4. Recent Initiatives

13.9. Sequenom

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial PerEnd-Userance

13.9.4. Recent Initiatives

13.10. Oxford Nanopore Technologies

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial PerEnd-Userance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The single nucleotide polymorphism (SNP) genotyping market size is expected to increase from USD 7.52 billion in 2025 to USD 42.12 billion by 2034.

The single nucleotide polymorphism (SNP) genotyping market is expected to grow at a compound annual growth rate (CAGR) of around 21.10% from 2025 to 2034.

The major players in the single nucleotide polymorphism (SNP) genotyping market include QIAGEN N.V, Bio-Rad Laboratories, Danaher Corporation, Beckman Coulter, Luminex Corporation, PerkinElmer, and Fluidigm Corporation.

The driving factors of the single nucleotide polymorphism (SNP) genotyping market are the advancements in genomic technology, the rise in fatal and chronic diseases, the expansion of SNP genotyping applications, and substantial government funding for R&D in the pharma and biotech sectors worldwide.

North America region will lead the global single nucleotide polymorphism (SNP) genotyping market during the forecast period 2025 to 2034.